You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart

Article: P03 PREVALENCE OF HETEROZYGOUS TYPE 2N VON WILLEBRAND DISEASE MUTATIONS IN A BELGIAN SURVEY

€3.03

SKU: product-article-23750 Category: General

Description
Reviews (0)

Description

P03 PREVALENCE OF HETEROZYGOUS TYPE 2N VON WILLEBRAND DISEASE MUTATIONS IN A BELGIAN SURVEY

Reviews

There are no reviews yet.

Be the first to review “Article: P03 PREVALENCE OF HETEROZYGOUS TYPE 2N VON WILLEBRAND DISEASE MUTATIONS IN A BELGIAN SURVEY”

You must be logged in to post a review.

Top

Article: P03 PREVALENCE OF HETEROZYGOUS TYPE 2N VON WILLEBRAND DISEASE MUTATIONS IN A BELGIAN SURVEY

Description

Reviews

Related products

1 year access Online Belgian Journal of Hematology (BJH)

Article: Highlights in breast cancer

Article: INTRODUCTION

Article: Highlights in breast cancer